27 related articles for article (PubMed ID: 3137887)
21. Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres.
Taguchi T
Clin Pharmacokinet; 1994 Apr; 26(4):275-91. PubMed ID: 8013161
[TBL] [Abstract][Full Text] [Related]
22. Microparticulate drug delivery systems as an adjunct to cancer treatment.
Kerr DJ
Cancer Drug Deliv; 1987; 4(1):55-61. PubMed ID: 3300944
[TBL] [Abstract][Full Text] [Related]
23. [Hepatic arterial infusion of degradable starch microspheres (DSM) with adriamycin or mitomycin C in liver cancer].
Ota J; Fujita M; Nakamura H; Taguchi T
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2640-5. PubMed ID: 3137887
[TBL] [Abstract][Full Text] [Related]
24. [Liver tumor targeting of drugs: Spherex, a vascular occlusive agent].
Taguchi T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):969-76. PubMed ID: 7794007
[TBL] [Abstract][Full Text] [Related]
25. Spherex (degradable starch microspheres) chemo-occlusion--enhancement of tumor drug concentration and therapeutic efficacy: an overview.
Håkansson L; Håkansson A; Morales O; Thorelius L; Warfving T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-100-S6-109. PubMed ID: 9151924
[TBL] [Abstract][Full Text] [Related]
26. [Recent progress in multidisciplinary treatment of hepatic cancer].
Fujita M; Nakamura H; Taguchi T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1000-7. PubMed ID: 2543301
[TBL] [Abstract][Full Text] [Related]
27. [Clinical effectiveness of degradable starch microspheres (DSM) in patients with liver cancer].
Kumada T; Nakano S; Sone Y; Kiriyama S; Hisanaga Y; Rikitoku T; Tamoto A; Honda T
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1678-83. PubMed ID: 10560370
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
